You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Dow
McKinsey
Boehringer Ingelheim
Merck

Last Updated: March 3, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CHLORZOXAZONE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Chlorzoxazone

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00330434 Effect of Ethanol and Genetic Polymorphisms on Bupropion Metabolism Completed National Institute on Alcohol Abuse and Alcoholism (NIAAA) N/A 2005-12-01 The two purposes of this study are 1. to determine what effect the chronic and moderate/heavy drinking of alcoholic beverages has 1. on the blood level of bupropion and chlorzoxazone and their major breakdown products in the blood and 2. on the stimulant effect of bupropion and 2. to determine what effect a normal and common (25% frequency) genetic variation of a specific liver enzyme (that breaks down bupropion) has 1. on the blood levels of bupropion and its major breakdown products in the blood and 2. on the stimulant effect of bupropion. Two groups of volunteers will be recruited for this study: 1. volunteers who drink moderate to heavy amounts of alcohol frequently and 2. volunteers who usually do not drink alcohol. Volunteers will NOT be asked to change their drinking (or nondrinking) habits during the study.
NCT01187862 Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of Cytochromes Completed University Hospital, Basel, Switzerland Phase 1 2010-07-01 The purpose of this study is to assess whether a cocktail of seven approved drugs (so-called "Basel cocktail") can be used for simultaneous phenotyping of CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A4.
NCT01342341 Placebo-Controlled Cross Over Trial of Chlorzoxazone Intake Completed University of California, San Francisco Phase 4 2011-04-01 The overall goals of this study are to (1) expand knowledge about interactions of chlorzoxazone with alcohol by assessing the effects of chlorzoxazone compared to placebo in moderate and heavy social alcohol users and (2) to compare the effects of chlorzoxazone on visual cue induced alcohol craving to placebo in moderate to heavy social alcohol users.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Chlorzoxazone

Condition Name

Condition Name for Chlorzoxazone
Intervention Trials
Type 2 Diabetes 1
Bariatric Surgery Candidate 1
Metastatic Breast Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Chlorzoxazone
Intervention Trials
Osteoarthritis, Hip 1
Alcohol Drinking 1
Osteoarthritis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Chlorzoxazone

Trials by Country

Trials by Country for Chlorzoxazone
Location Trials
Denmark 2
United States 2
Czechia 1
Switzerland 1
Germany 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Chlorzoxazone
Location Trials
California 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Chlorzoxazone

Clinical Trial Phase

Clinical Trial Phase for Chlorzoxazone
Clinical Trial Phase Trials
Phase 4 4
Phase 2 1
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Chlorzoxazone
Clinical Trial Phase Trials
Completed 5
Recruiting 3
Enrolling by invitation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Chlorzoxazone

Sponsor Name

Sponsor Name for Chlorzoxazone
Sponsor Trials
Northern Orthopaedic Division, Denmark 1
Diabetes Research Foundation, Finland 1
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Chlorzoxazone
Sponsor Trials
Other 14
Industry 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Dow
AstraZeneca
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.